Robert Norman Barker

Title: Innovations and Contributions of Robert Norman Barker

Introduction

Robert Norman Barker is a notable inventor based in Inverurle, GB. He has made significant contributions to the field of immunology, holding a total of three patents. His work focuses on developing innovative solutions for immune-related conditions.

Latest Patents

One of his latest patents is titled "Antibodies specifically directed to a soluble form of CTLA-4." This invention provides materials and methods related to antibodies that target a soluble form of CTLA-4 (sCTLA-4). These antibodies have demonstrated a strong boosting effect on antigen-specific human immune responses. Another significant patent is "Use of platelet glycopeptide IIIa epitopes in the treatment of immune thrombocytopenic purpura." This invention relates to a composition designed to treat diseases associated with autoantibodies specific for platelet proteins, particularly autoimmune thrombocytopenic purpura. The composition, which includes an epitope of a platelet protein, aims to treat diseases through tolerization.

Career Highlights

Throughout his career, Robert has worked with esteemed institutions, including the University Court of the University of Aberdeen and Aberdeen University. His research and innovations have contributed to advancements in medical treatments and therapies.

Collaborations

Robert has collaborated with notable individuals in his field, including Stanislaw Joseph Urbaniak and Frank James Ward. Their combined expertise has furthered the development of innovative solutions in immunology.

Conclusion

Robert Norman Barker's contributions to the field of immunology through his patents and collaborations highlight his dedication to advancing medical science. His work continues to impact the treatment of immune-related conditions, showcasing the importance of innovation in healthcare.